Adverse Event Reporting
| VAERS ID | 1509423 |
|---|---|
| Gender | Female |
| Age | |
| StateCode | FR |
| Pharmaceutical Company | PFIZER\BIONTECH |
| Lot Number | FC1439 |
| Number of vaccinations | |
| Vaccinated | 2021-06-25 |
| Onset | 2021-07-07 |
| Condition | Died |
Symptoms
- SARS-CoV-2 test
- Electrocardiogram
- Dyspnoea exertional
- Pulmonary embolism
- Heart rate
- Oxygen saturation
- Cardio-respiratory arrest
- Deep vein thrombosis
Current Illness
Preexisting Conditions
Other Medications
CITALOPRAM; LORAZEPAM
Previous Vaccinations
Allergies
Laboratory Data
Test Date: 20210707; Test Name: EKG; Result Unstructured Data: Test Result:without significant alterations; Comments: narrow QRS, no repolarization disorders, good vesicular murmur without pathological noises; Test Date: 20210707; Test Name: heart rate; Result Unstructured Data: Test Result:128; Comments: bpm; Test Date: 20210707; Test Name: o2 saturation; Result Unstructured Data: Test Result:no contribution 85/88% with 02 95% %; Test Date: 20210707; Test Name: Rapid antigen test; Test Result: Negative
Write-up
Pulmonary thromboembolism; Venous thrombosis deep limb; Dyspnea/moderate dyspnea with an effort; Cardio-respiratory arrest; This is a spontaneous report from a contactable healthcare professional downloaded from the Medicines Agency (MA) -WEB, regulatory authority number ES-AEMPS-940805.
A 40-year-old female patient received BNT162B2 (COMIRNATY, solution for injection, lot number: FC1439), via an unspecified route of administration on 25Jun2021 as dose number unknown, single for COVID-19 immunization.
The patient medical history was not reported.
Concomitant medications included citalopram and lorazepam, both taken for unspecified indications, start and stop dates were not reported.
The patient experienced pulmonary thromboembolism, venous thrombosis deep limb, dyspnea/moderate dyspnea with an effort and cardio-respiratory arrest on 07Jul2021.
It was reported that the patient was attending the emergency room due to dyspnea.
The patient is evaluated in the emergency room of the health center, and for this reason she has been referred to a hospital emergency room.
Riding in her vehicle, she has started to get worse.
She has had moderate dyspnea with an effort for 5 days, which has progressively worsened, which was why she went to the emergency room.
The patient began to worsen in consultation, entering cardiorespiratory arrest at approximately 8.
30 PM, beginning advanced CPR maneuvers.
061: Upon arrival of the emergency team, she did not present a pulse, did not present spontaneous breathing, CPR maneuvers were being performed by health personnel.
Final CRP: 10:10 PM.
Autopsy showed pulmonary embolism and deep vein thrombosis in the right lower limb.
The patient underwent lab tests and procedures which included EKG: narrow QRS, no repolarization disorders, good vesicular murmur without pathological noises, heart rate: 128 bpm , oxygen (O2) saturation: no contribution 85/88% with 02 95% and rapid antigen test: negative, all on 07Jul2021.
The outcome of all events was fatal.
The patient died on 07Jul2021 due to all events.
An autopsy was performed that revealed pulmonary thromboembolism and venous thrombosis deep limb.
No follow-up attempts are possible.
No further information is expected.
; Reported Cause(s) of Death: Venous thrombosis deep limb; Pulmonary thromboembolism; Dyspnea/moderate dyspnea with an effort; Cardio-respiratory arrest; Autopsy-determined Cause(s) of Death: Pulmonary thromboembolism; Venous thrombosis deep limb